Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
GLP-1 receptor agonist medications were originally developed to treat type 2 diabetes and were found to cause weight loss while also decreasing the risk of cardiovascular events such as heart attacks and strokes in people with diabetes
Patients should seek medical attention if they experience severe or persistent gastrointestinal symptoms, signs of pancreatitis (severe abdominal pain radiating to the back), symptoms of thyroid tumors (neck mass, difficulty swallowing, persistent hoarseness), right upper quadrant pain, jaundice, reduced urine output, or unexplained hypoglycemia
Rybelsus Rybelsus is the only GLP-1 receptor agonist available in pill form, prescribed mainly for type 2 diabetes and sometimes used off-label for weight loss
Provider-determined dose and weekly cadence
Use these tools to better understand medication units, BMI, body composition, and weight loss program options
The body interprets rapid fat loss as a significant stressor, releasing inflammatory mediators as part of the adaptive response
US$ 20.52
US$ 20.24
US$ 29.91
US$ 24.74
US$ 21.02
US$ 21.54
